Differential expression of human nucleoside transporters in normal and tumor tissue.
about
Comparative genomic analysis of equilibrative nucleoside transporters suggests conserved protein structure despite limited sequence identity.Reduced Ribavirin Antiviral Efficacy via Nucleoside Transporter-Mediated Drug ResistanceTransporters at CNS barrier sites: obstacles or opportunities for drug delivery?Human concentrative nucleoside transporter 3 transfection with ultrasound and microbubbles in nucleoside transport deficient HEK293 cells greatly increases gemcitabine uptake.Equilibrative nucleoside transporters-A review.Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma.Xenobiotic, bile acid, and cholesterol transporters: function and regulation.PharmGKB summary: gemcitabine pathwayMolecular determinants of specificity for synthetic nucleoside analogs in the concentrative nucleoside transporter, CNT2.Equilibrative nucleoside transporter 1 genotype, cytidine deaminase activity and age predict gemcitabine plasma clearance in patients with solid tumours.Molecular biology and regulation of nucleoside and nucleobase transporter proteins in eukaryotes and prokaryotes.Direct or indirect stimulation of adenosine A2A receptors enhances bone regeneration as well as bone morphogenetic protein-2.Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy.Enhancing Drug Efficacy and Therapeutic Index through Cheminformatics-Based Selection of Small Molecule Binary Weapons That Improve Transporter-Mediated Targeting: A Cytotoxicity System Based on Gemcitabine.Pentose phosphates in nucleoside interconversion and catabolism.Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy.Concentrative nucleoside transporter 1 (hCNT1) promotes phenotypic changes relevant to tumor biology in a translocation-independent mannerThe role of mitochondrial and plasma membrane nucleoside transporters in drug toxicity.Physiology of nucleoside transporters: back to the future. . . .Equilibrative nucleoside transporter 1 plays an essential role in cardioprotectionFluorinase: a tool for the synthesis of ¹⁸F-labeled sugars and nucleosides for PET.Transport characteristics of HL-1 cells: a new model for the study of adenosine physiology in cardiomyocytes.Dilazep analogues for the study of equilibrative nucleoside transporters 1 and 2 (ENT1 and ENT2).Antibody-mediated enzyme replacement therapy targeting both lysosomal and cytoplasmic glycogen in Pompe disease.Expression of gemcitabine- and cisplatin-related genes in non-small-cell lung cancer.Hepatocyte nuclear factor-4alpha and bile acids regulate human concentrative nucleoside transporter-1 gene expression.Inosine and equilibrative nucleoside transporter 2 contribute to hypoxic preconditioning in the murine cardiomyocyte HL-1 cell line.Identification of the mitochondrial targeting signal of the human equilibrative nucleoside transporter 1 (hENT1): implications for interspecies differences in mitochondrial toxicity of fialuridine.Subtype-specific regulation of equilibrative nucleoside transporters by protein kinase CK2.Impact of Genetic Polymorphisms on 6-Thioguanine Nucleotide Levels and Toxicity in Pediatric Patients with IBD Treated with Azathioprine.Molecular evolution of the equilibrative nucleoside transporter family: identification of novel family members in prokaryotes and eukaryotes.Functional differences in nucleoside and nucleobase transporters expressed on the rabbit corneal epithelial cell line (SIRC) and isolated rabbit cornea.Localization of broadly selective equilibrative and concentrative nucleoside transporters, hENT1 and hCNT3, in human kidney.PKC regulation of the human equilibrative nucleoside transporter, hENT1.Comparison of the interaction of uridine, cytidine, and other pyrimidine nucleoside analogues with recombinant human equilibrative nucleoside transporter 2 (hENT2) produced in Saccharomyces cerevisiae.Molecular determinants of acidic pH-dependent transport of human equilibrative nucleoside transporter 3.Role of nucleoside transporters in nucleoside-derived drug sensitivity.Immunohistochemical expression profiles of solute carrier transporters in alpha-fetoprotein-producing gastric cancer.Nucleoside transporters are widely expressed in ovarian carcinoma effusions.
P2860
Q24537625-71EDBDAC-0ECC-4796-990B-1BD171910FA6Q27488307-B47E4219-D05F-435E-AF96-C79514142B6BQ27690256-3390E0EA-D6C5-49E8-9BDF-6B9475FFB3D5Q28486221-2F91D53F-47EB-4598-AC14-17C256C5DDDEQ30244329-D16FA688-7389-45A3-ADA5-C884749B7B83Q33336057-07B1D09F-D8F0-43A8-B43D-6AA4EF8C2020Q33714593-20F6CD40-75EC-42C8-BABA-8126314CCC2DQ34435450-673E02FB-F87B-405C-81F8-E052B13C04BDQ34547445-AF50DCAF-DEAA-4295-86FA-763888BF2649Q34609029-34696D08-5AE1-4760-8AC8-FE2F7F550254Q35003182-152B83EB-A601-485B-ADF5-3FC5D2233535Q35410561-098F94E8-EE8D-4728-8003-D0E87BCB0C5EQ35567292-94015818-D341-4494-A83B-9285F9DD4D0AQ36342657-8E99F3D5-1679-4528-92EE-389EAF498782Q36414892-91D24298-AEC1-4FC3-8ECF-A67C013F89E9Q36709135-08D1AD80-6A52-4141-A2A5-7A5D7DD70861Q36907164-D1CB18CD-7A95-4108-A418-39B90D36361FQ36960546-B7FBFA65-BE67-49BD-B71F-A378D6D6A652Q37082372-0FD1DE8B-595B-42B8-9946-B0B46459036AQ37174112-FED1F4BD-5FD2-47B7-BC16-9E869FAD7C43Q37855878-096246A6-729A-42A6-AD08-AE2F52C5AF5CQ38360778-79D35E45-38DA-49D5-9614-1303DE56C604Q38934256-067AF200-6B24-4F47-A623-8BC757340DABQ38982768-E5474923-41EE-4827-9A5C-875581E5CB65Q39776948-4ACBDE80-80C4-45AE-B860-5B2124B1270CQ39881960-EDAE7E2E-129C-4577-AD88-D16B042E6D3FQ39990412-F43CE583-590A-4E18-8559-278291B02F91Q40295834-5C5694BA-5343-40D8-B3E8-0B917F991F3DQ40500827-A1855193-1F61-4674-8979-8688260A78A7Q40582133-D8EAA584-F088-4A69-8B5F-3640307CAA9DQ40620185-8D310D3B-C24C-45EE-BA10-EE5A76630A2EQ41847964-2463806D-39AB-486C-9F5C-2FBCE4A21544Q42510645-CBB87150-8FCC-4A33-B34F-0278493EA060Q44026020-CBA36C4D-758D-40D9-BA89-79C5534F6065Q44221920-07C4A7C2-D11E-480E-B3CC-B311BD42B8ADQ48516800-FB7A2314-3A16-400E-B938-175995CE7646Q50575119-E7449E57-585D-459A-B652-8EC5D0C40E4DQ51728141-93D8196C-265A-49FE-A20E-A166BD5EBA6CQ53148496-0241BE18-3A49-4181-A109-A1C83611FA74
P2860
Differential expression of human nucleoside transporters in normal and tumor tissue.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Differential expression of human nucleoside transporters in normal and tumor tissue.
@ast
Differential expression of human nucleoside transporters in normal and tumor tissue.
@en
type
label
Differential expression of human nucleoside transporters in normal and tumor tissue.
@ast
Differential expression of human nucleoside transporters in normal and tumor tissue.
@en
prefLabel
Differential expression of human nucleoside transporters in normal and tumor tissue.
@ast
Differential expression of human nucleoside transporters in normal and tumor tissue.
@en
P2093
P356
P1476
Differential expression of human nucleoside transporters in normal and tumor tissue.
@en
P2093
P304
P356
10.1006/BBRC.2000.4205
P407
P577
2001-01-01T00:00:00Z